Resources

Your selections:

Clear all

Show Filters

We found 236 resources that match your search.

Document Date:

COMBIVIR, a combination of 2 nucleoside analogue reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. 

Document Date:

Line by line instructions for how to complete the Expedited Adverse Events reporting form.

Document Date:

Lists of IND and non-IND protocols having case report forms (CRFs) and pharmacy records that will not be stored by DAIDS .

Document Date:

COZAAR is an angiotensin II receptor blocker (ARB) indicated for:

Document Date:

Quick reference card for creating a new submission in the DPRS.

Document Date:

CRF master inventory list template.

Document Date:

Term definitions and access rights for Reporters and Submitters using DAERS.

Document Date:

Technical guide to the DAERS system for Site Enrollment users.

Document Date:

Detailed manual on the DAERS system for Site Reporters and Study Physicians.

Document Date:

Formatted specifically for printing. applicable, to special instructions to keep in mind while entering values.

Document Date:

Who are DAIDS collaborators? How are they involved in the protocol development lifecycle? And other information about collaborators.

Document Date:

Guidance regarding the DAIDS deregistration process.

Document Date:

Process for collection of financial disclosure by clinical investigators conducting DAIDS-sponsored IND trials.

Document Date:

Guidance for implementing protocol clarifications or changes.

Document Date:

DAIDS investigator of record form (3/2017).

Document Date:

DAIDS investigator of record form (3/2017).

Document Date:

DAIDS letter of Amendment template for a protocol.

Document Date:

DAIDS Memo Regarding Timing of Consent and Re-Consent with Updated IRB/EC/RE-Approved Informed Consent Forms.

Document Date:

DAIDS protocol registration basic training.

Document Date: